Opening book details…
About this Medicine article
Adalimumab Therapy maintains meaningful rates of steroid-free remission in patients with Crohnʼs Disease for up to 3 Years of Therapy: Results From an Open-Label Extension of CHARM by Kamm, M; Hanauer, S; Panaccione, R; Colombel, J; Sandborn, W; Lomax, K; Pollack, P is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Kamm, M; Hanauer, S; Panaccione, R; Colombel, J; Sandborn, W; Lomax, K; Pollack, P
- Publisher
- John Wiley and Sons; Oxford University Press; Oxford University Press (OUP) (ISSN 1078-0998)
- Published
- 2009
- Field
- Medicine (Health Sciences)